Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Susan Foden Insider Profile
4 Followers
Susan Foden, Director at Vectura, holds 725.00K shares in Evgen Pharma (Ticker: GB:TCF), holds 17.50K shares in Vectura (Ticker: GB:VEC). Most recently, Susan Foden Bought ― shares of Evgen Pharma on Mar 20, 2024 for an estimated value of 6.00K.
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-32.30%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Susan Foden holds in companies
Most Profitable Insider Trade
The most profitable trade made by Susan Foden
Susan Foden's Trading History
Vectura
Oct 03, 2016
―
Informative Buy
9.07K
£28.84K
Evgen Pharma
Mar 20, 2024
Director
Informative Buy
6.00K
£5.80K
List of latest transactions for each holding click on a transaction to see Susan Foden's performance on stock
You May Also Like
Susan Foden insider profile FAQ
What is the percentage of profitable transactions made by Susan Foden?
The percentage of profitable transactions made by Susan Foden is 0%.
What is the average return per transaction made by Susan Foden?
The average return per transaction made by Susan Foden is -32.30%.
What stocks does Susan Foden hold?
Susan Foden holds: GB:VEC, GB:TCF stocks.
What was Susan Foden’s latest transaction?
Susan Foden latest transaction was an Informative Buy of 6.00K.
What was Susan Foden's most profitable transaction?
Susan Foden’s most profitable transaction was an Informative Buy of GB:TCF stock on March 20, 2024. The return on the trade was -17.90%.
What is Susan Foden's role in Vectura?
Susan Foden's role in Vectura is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.